adult ventricular assist device
PROVEN. TRUSTED. COMMITTED.
Forty-five percent of all heart transplants are bridged to transplant with a ventricular assist device (VAD). The Medtronic commitment to advance the treatment of end-stage heart failure has never been stronger.
The HeartWare™ HVAD™ System is the most widely studied implanted centrifugal ventricular device.
Over 2,000 patients are enrolled in HeartWare HVAD trials.
As many as 350 hospitals trust the HeartWare HVAD System. It's used in 47 countries and serves more than 15,000 patients worldwide.
We continually learn and innovate, further advancing the treatment of end-stage heart failure. We are always striving to improve patient outcomes and the clinical experience of your practice.